• Zum Hauptinhalt springen
  • Zum Footer springen
  • Deutsch - de
  • English - en

    SyNergy - Mu...

    • About
      • About us
      • Our Measures
      • Members
      • Cluster Management
      •  PhD & Postdoc representatives
      • Scientific Advisory Board
      •  International cooperation partners
      • Timeline
      •  Media Kit
      • Contact
    • News & Events
      • News
      • Events
      • In the News
      • Open Positions
    • Research
      • Publications
      • Our Research Focus
      • Technology Hubs
      • Research Spotlight
      • Research Data Management
      • Sustainability Initiative
      •  Code of Conduct
    • Science & Society
      • For Schools & Students
      • Public Events
      • Podcasts
      • Videos
    • Support for Diversity & Equity
      • Newcomer Center
      • Gender Equality Program
      • Early Career Investigator Program
    1. Home
    2. News & Events
    3. News
    4. A new ally in fighting brain diseases: our very own skull
    News | 16/08/2023 | Press Release

    A new ally in fighting brain diseases: our very own skull

    Alzheimer's, stroke, multiple sclerosis, and other neurological diseases cause severe damage due to neuroinflammation mediated by immune cells. Managing this inflammation poses a significant medical challenge because the brain is protected by the skull and additional surrounding membranes that make the brain less accessible for treatment approaches. Scientists had previously discovered pathways going from the bone marrow of the skull towards the brain, allowing immune cell movement. Now, new research revealed that cells in the skull’s bone marrow are unique in their composition and in their disease response. These findings offer new possibilities for the diagnosis and treatment of neurological diseases and revolutionize brain health monitoring in the future with non-invasive skull imaging. The results are now published in Cell.
    Cell, https://doi.org/10.1016/j.cell.2023.07.009

    Neurological diseases such as Alzheimer's, stroke, and multiple sclerosis have a devastating impact on the lives of millions worldwide. A common feature is neuroinflammation, an internal "fire" in the brain that can cause severe damage by activation of immune cells and release of inflammatory molecules. However, due to the brain's relative inaccessibility, as it is shielded by the skull and three additional layers of protection in the form of membranes, controlling and monitoring this inflammation has been a major challenge. A team of scientists around Prof. Ali Ertürk at Helmholtz Munich in collaboration with researchers from the Ludwig-Maximilians-Universität München (LMU) and the Technical University of Munich (TUM) sought to address this unmet need.

    • Read the full press release on the website of Helmholtz Munich

    Participating Universities
     LMU logo in white
     TUM logo in white
    Partner Institutions
     Logo DZNE in white
    Helmholtz Munich logo in white 
     Logo Max Planck Gesellschaft 

    SyNergy is funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the German Excellence Strategy (EXC 2145 SyNergy – ID 390857198). The Excellence Strategy promotes outstanding research at German universities. 

    Contact

    Munich Cluster for Systems Neurology (SyNergy)

    Feodor-Lynen-Str. 17
    81377 Munich
    +49 (0)89 4400-46497
    Dyüubgybcјuipdxјrvfulyz mi
    Editor login
    Imprint | Data-Safety